3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Toxemia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Myocarditis
1
Muscle Weakness
1
Melanoma
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma in Situ
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Fluorouracil
14
pembrolizumab
13
Paclitaxel
13
Oxaliplatin
13
Leucovorin
10
Carboplatin
9
Radiotherapy
8
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Drug Therapy
7
Cisplatin
7
Radiation
6
Esophagectomy
6
Taxes
5
Specimen Handling
5
Surgical Procedures, Operative
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
Blood Specimen Collection
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Positron-Emission Tomography
×
90 days
×
Clear all
No trials found.